Mitarbeiter: 11 (2023.0)Rechtsform: 5785Größe: PMEGründungsdatum: 2005-11-25 (20 Jahre)Status: AktivBranche: Commerce de détail de produits pharmaceutiques en magasin spécialiséStandort: CARCASSONNE (11000), Aude
GRANDE PHARMACIE DE LA GARE : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE LA GARE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CARCASSONNE (11000),
this company of category PME
shows in 2022 a revenue of 3.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Historique financier - GRANDE PHARMACIE DE LA GARE (SIREN 485172357)
Kennzahl
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Umsatz
N/C
N/C
3 133 804 €
N/C
N/C
N/C
8 022 035 €
9 697 176 €
10 686 664 €
11 300 976 €
11 432 289 €
Nettoergebnis
235 732 €
-482 106 €
-499 073 €
61 864 €
83 287 €
285 486 €
32 925 €
62 727 €
165 698 €
277 821 €
338 657 €
EBITDA
N/C
N/C
-449 197 €
N/C
N/C
N/C
-53 691 €
123 951 €
189 200 €
409 556 €
529 898 €
Nettomarge
N/C
N/C
-15.9%
N/C
N/C
N/C
0.4%
0.6%
1.6%
2.5%
3.0%
Umsatz und Gewinn- und Verlustrechnung
In 2024, GRANDE PHARMACIE DE LA GARE generates positive net income of 236 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2024: 339 k€ -> 236 k€.
Nettoergebnis (2024)
?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Anzeigen :
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Aktiva
Chargement des données...
Poste
Brutto
Abschr.
Netto
%
Entwicklung
Données de bilan actif non disponibles pour cette entreprise
Passiva
Chargement des données...
Poste
Jahr
%
Entwicklung
Données de bilan passif non disponibles pour cette entreprise
Solvenz- und Verschuldungskennzahlen
The debt ratio (= Financial debt / Equity x 100) stands at 2099%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Verschuldungsgrad (2024)
?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible 50-100% : Moderat > 100% : Hoch
2098.768%
Finanzielle Autonomie (2024)
?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Entwicklung der Solvenzkennzahlen GRANDE PHARMACIE DE LA GARE
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Verschuldungsgrad
105.503
75.753
51.791
71.427
117.997
93.151
171.71
156.878
199.026
-3048.037
2098.768
Finanzielle Autonomie
27.381
33.606
37.372
34.529
31.194
34.685
27.87
29.931
24.699
-2.551
3.357
Rückzahlungsfähigkeit
2.805
2.999
3.796
6.592
-12.097
None
None
None
-4.419
None
None
Cashflow / Umsatz
3.989%
3.33%
2.114%
1.325%
-1.397%
None%
None%
None%
-15.555%
None%
None%
Positionnement sectoriel
Debt ratio
2098.772024
2022
2023
2024
Q1: 16.45
Méd: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of GRANDE PHARMACIE DE LA GARE (2098.77) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
3.36%2024
2022
2023
2024
Q1: 28.92%
Méd: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of GRANDE PHARMACIE DE LA GARE (3.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
-4.42 years2022
2022
Q1: 1.29 years
Méd: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of GRANDE PHARMACIE DE LA GARE (-4.42) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquiditätskennzahlen
The liquidity ratio (= Current assets / Current liabilities) stands at 261.67. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquiditätsquote (2024)
?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut 1-1.5 : Angemessen < 1 : Risque de liquidité
261.667
Entwicklung der Liquiditätskennzahlen GRANDE PHARMACIE DE LA GARE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Kennzahl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquiditätsquote
147.373
164.18
158.43
150.322
193.27
204.127
306.17
326.523
300.299
313.251
261.667
Zinsdeckung
7.494
7.391
13.527
17.547
-29.694
None
None
None
-2.064
None
None
Positionnement sectoriel
Liquidity ratio
261.672024
2022
2023
2024
Q1: 129.47
Méd: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of GRANDE PHARMACIE DE LA GARE (261.67) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
-2.06x2022
2022
Q1: 0.75x
Méd: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of GRANDE PHARMACIE DE LA GARE (-2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Umlaufvermögensbedarf und Zahlungsfristen
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operatives Working Capital (2024)
?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität
0 j
Lagerumschlag (2024)
?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag
0 j
Entwicklung des Working Capital und der Zahlungsfristen GRANDE PHARMACIE DE LA GARE
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
BFR d'exploitation
2 145 269 €
2 477 739 €
2 625 606 €
2 451 543 €
1 946 787 €
0 €
0 €
0 €
1 801 593 €
0 €
0 €
Lagerumschlag (Tage)
55
54
61
62
59
0
0
0
188
0
0
Crédit clients (jours)
10
14
12
15
14
0
0
0
17
0
0
Crédit fournisseurs (jours)
60
58
64
63
49
0
0
0
98
0
0
Positionnement de GRANDE PHARMACIE DE LA GARE dans son secteur
Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé
Bewertungsschätzung
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DE LA GARE is estimated at
3 290 992 €
(range 2 291 795€ - 4 923 513€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2291k€3290k€4923k€
3 290 992 €Range: 2 291 795€ - 4 923 513€
NAF 5 année 2024
Valuation method used
Net Income Multiple
235 732 €
×
14.0x
=3 290 993 €
Range: 2 291 795€ - 4 923 514€
Only this financial indicator is available for this company.
Bewertungsentwicklung
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE LA GARE with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE LA GARE
What is the revenue of GRANDE PHARMACIE DE LA GARE ?
The revenue of GRANDE PHARMACIE DE LA GARE in 2022 is 3.1 M€.
Is GRANDE PHARMACIE DE LA GARE profitable?
Yes, GRANDE PHARMACIE DE LA GARE generated a net profit of 236 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DE LA GARE ?
The headquarters of GRANDE PHARMACIE DE LA GARE is located in CARCASSONNE (11000), in the department Aude.
Where to find the tax return of GRANDE PHARMACIE DE LA GARE ?
The tax return of GRANDE PHARMACIE DE LA GARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE LA GARE operate?
GRANDE PHARMACIE DE LA GARE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Drehen Sie Ihr Telefon ins Querformat, um das Diagramm anzuzeigen